Application of microbial assay for risk assessment biotest in evaluation of toxicity of human and veterinary antibiotics

Environmental Toxicology

Volumn 25, Issue 5, 2010, Pages 487-494

  Nałȩcz Jawecki, Grzegorz ^a   Wadhia, K ^b   Adomas, B ^c   Piotrowicz Cieslak A I ^c   Sawicki, J ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b NCIMB Ltd   (United Kingdom)

^c UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

Author keywords

Antibiotics; Bioassay; MARA; Microbial

Indexed keywords

ANTIBACTERIALS; BELONG TO; GROWTH INHIBITION; MARA; MICROBIAL; MICROBIAL ASSAY; MICROBIAL SPECIES; MICROBIAL STRAIN; MICROBIAL TOXIC; MICROPLATE TOXICITY TEST; MICROPLATES; MULTI-SPECIES; PHYLOGENETIC GROUPS; QUINOLONES; SECOND GENERATION; TEST SAMPLES; TOXIC RESPONSE; VETERINARY ANTIBIOTIC;

ANTIBIOTICS; BIOASSAY; MICROORGANISMS; RISK ASSESSMENT; STRAIN;

TOXICITY;

ANTIBIOTIC AGENT; CHLORTETRACYCLINE; CIPROFLOXACIN; FLEROXACIN; LOMEFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; OXOLINIC ACID; OXYTETRACYCLINE; PEFLOXACIN MESILATE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; SULFADIAZINE; TETRACYCLINE DERIVATIVE; TIAMULIN; VETERINARY DRUG;

ANTIBIOTICS; BIOASSAY; INHIBITION; MICROBIAL ACTIVITY; MICROBIAL COMMUNITY; RISK ASSESSMENT; TOXICITY;

ANTIBIOTIC SENSITIVITY; ARTICLE; ASSAY; BACTERIAL STRAIN; BIOASSAY; GROWTH INHIBITION; PHYLOGENY; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TOXICITY TESTING;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BIOLOGICAL ASSAY; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICROBIOLOGICAL TECHNIQUES; QUINOLONES; RISK ASSESSMENT; TETRACYCLINES; TOXICITY TESTS; VETERINARY DRUGS; WATER MICROBIOLOGY;

EID: 77957660121     PISSN: 15204081     EISSN: 15227278     Source Type: Journal    
DOI: 10.1002/tox.20593     Document Type: Article

References (35)

1. Alexy R, Kümpel T, Kümmerer K. 2004. Assessment of degradation of 18 antibiotics in the Closed Bottle Test. Chemosphere 57:505-512. (Pubitemid 39179769)
2. Backhaus T, Grimme LH. 1999. The toxicity of antibiotic agents to the luminescent bacterium Vibrio fischeri. Chemosphere 38:3291-3301. (Pubitemid 29189026)
3. Backhaus T, Scholze M, Grimme LH. 2000. The single substance and mixture toxicity of quinolones to the bioluminescent bacterium Vibrio fischeri. Aquat Toxicol 49:49-61. (Pubitemid 30256153)
4. Brain RA, Wilson CJ, Johnson DJ, Sanderson H, Bestari K, Hanson ML, Sibley PK, Solomon KR. 2005. Effects of a mixture of tetracyclines to Lemna gibba and Myriophyllum sibiricum evaluated in aquatic microcosms. Environ Pollut 138:425-442. (Pubitemid 41140398)
5. Carlsson C, Johansson A-K, Alvan G, Bergman K, Kuhler T. 2006. Are pharmaceuticals potent environmental pollutants? I. Environmental risk assessment of selected active pharmaceutical ingredients. Sci Total Environ 364:67-87.
6. Crane M, Watts Ch, Boucard T. 2006. Chronic aquatic environmental risks from exposure to human pharmaceuticals. Sci Total Environ 367:23-41. (Pubitemid 44177509)
7. Duong HA, Pham NH, Nguyen HT, Hoang TT, Pham HV, Pham VC, Berg M, Giger W, Alder AC. 2008. Occurrence, fate and antibiotic resistance of fluoroquinolone antibacterials in hospital wastewaters in Hanoi. Vietnam. Chemosphere 72:968-973.
8. EMEA. European Agency for the Evaluation of Medicinal Products. Guideline on the environment al risk assessment of medicinal products for human use. London, 2006.
9. Fent K, Weston AA, Caminada D. 2006. Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76:122-159.
10. Gabrielson J, Kuhn I, Colque-Navarro P, Hart M, Iversen A, McKenzie D, Mollby R. 2003. Microplate-based microbial assay for risk assessment and (eco)toxic fingerprinting of chemicals. Anal Chim A 485:121-130. (Pubitemid 36577480)
11. Goossens H, Ferech M, Stichele RV, Elseviers M. 2005. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. Lancet 365:579-587.
12. Grung M, Kallqvist T, Sakshaug S, Skurtveit S, Thomas KV. 2007. Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline. Ecotoxicol Environ Saf 71:328-340.
13. Halling-Sorensen B. 2000. Algal toxicity of antibacterial agents used in intensive farming. Chemosphere 40:731-739.
14. Halling-Sorensen B. 2001. Inhibition of aerobic growth and nitrification of bacteria in sewage sludge by antibacterial agents. Arch Environ Contam Toxicol 40:451-460.
15. Hartmann A, Golet EM, Gartiser S, Alder AC, Koller T, Widmer RM. 1999. Primary DNA damage but not mutagenicity correlates with ciprofloxacin concentrations in german hospital wastewaters. Arch Environ Contam Toxicol 36: 115-119.
16. Hernando MD, De Vettori S, Martinez-Bueno MJ, Fernandez-Alba AR. 2007. Toxicity evaluation with Vibrio fischeri test of organic chemicals used in aquaculture. Chemosphere 68:724-730. (Pubitemid 46590282)
17. ISO 10712:1995. Water quality - Pseudomonas putida growth inhibition test (Pseudomonas cell multiplication inhibition test).
18. Jones OAH, Voulvoulis N, Lester JN. 2002. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Wat Res 36:5013-5022. (Pubitemid 35266826)
19. Kümmerer K, 2009a. Antibiotics in the aquatic environment - A review, Part I. Chemosphere 75:417-434.
20. Kümmerer K, 2009b. The presence of pharmaceutical in the environment due to human use - Present knowledge and future challenges. J Environ Manage 90:2354-2366.
21. Kümmerer K, Al-Ahmad A, Mersch-Sundermann V. 2000. Biodegradability of some antibiotics, elimination of the genotoxicity and affection of wastewater bacteria in a simple test. Chemosphere 40:701-710.
22. Kümmerer K, Alexy R, Hüttig J, Schöll A. 2004. Standardized tests fail to assess the effects of antibiotics on environmental bacteria. Water Res 38:2111-2116. (Pubitemid 38496210)
23. Larsson DGJ, de Pedro C, Paxeus N. 2007. Effluent from drug manufactures contains extremely high levels of pharmaceutical. J Hazardous Mater 148:751-755. (Pubitemid 47334856)
24. Lindberg R, Jarnheimer P-A, Olsen B, Johansson M, Tysklind M. 2004. Determination of antibiotic substances in hospital sewage water using solid phase extraction and liquid chromatography/mass spectrometry and group analogue internal standards. Chemosphere 57:1479-1488. (Pubitemid 39422328)
25. Mcardell ChS, Molnar E, Suter MJ-F, Giger W. 2003. Occurrence and fate of macrolide antibiotics in wastewater treatment plants and in the Glatt Valley Watershed. Switzerland. Environ Sci Technol 37:5479-5486. (Pubitemid 37541715)
26. Park S, Choi K. 2008. Hazard assessment of commonly used agricultural antibiotics on aquatic ecosystems. Ecotoxicology 17:526-538.
27. Roberts PH, Thomas KV. 2006. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci Total Environ 356:143-153.
28. Robinson AA, Beiden JB, Lydy MJ. 2005. Toxicity of fluoroquinolone antibiotics to aquatic organisms. Environ Toxicol Chem 24:423-430.
29. Sarmah AK, Meyer MT, Boxall AB. 2006. A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment. Chemosphere 65:725-759.
30. Ternes TA. 1998. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32:3245-3260.
31. Van den Brink PJ, Tarazona JV, Solomon KR, Knacker T. 2005. The use of terrestrial and aquatic microcosms and mesocosms for the ecological risk assessment of veterinary medicinal products. Environ Toxicol Chem 24:820-829. (Pubitemid 40404550)
32. Wadhia K, Dando T, Thompson KC. 2007. Intra-laboratory evaluation of Microbial Assay for Risk Assessment (MARA) for potential application in the implementation of the Water Framework Directive (WFD). J Environ Monit 9:953-958. (Pubitemid 47340661)
33. Webb S. 2001. A data-based perspective on the environmental risk assessment of human pharmaceuticals. I. Collation of available ecotoxicity data. In: Kümmerer K, editor. Pharmaceuticals in the Environment. Sources, Fate, Effects and Risks. Berlin, Heidelberg, New York: Springer-Verlag. pp 175-201.
34. Wollenberger L, Halling-Sorensen B, Kusk KO. 2000. Acute and chronic toxicity of veterinary antibiotics to Daphnia magna. Chemosphere 40:723-730. (Pubitemid 30085794)
35. Zuccato E, Bagnati R, Fioretti F, Natangelo M, Calamari D, Fanelli R. 2001. Environmental loads and detection of pharmaceuticals in Italy. In: Kümmerer K, editor. Pharmaceuticals in the Environment. Sources, Fate, Effects and Risks. Berlin, Heidelberg, New York: Springer-Verlag. pp 19-28.